全文获取类型
收费全文 | 514252篇 |
免费 | 34126篇 |
国内免费 | 630篇 |
专业分类
耳鼻咽喉 | 6966篇 |
儿科学 | 16844篇 |
妇产科学 | 13605篇 |
基础医学 | 85177篇 |
口腔科学 | 14515篇 |
临床医学 | 44329篇 |
内科学 | 93588篇 |
皮肤病学 | 12210篇 |
神经病学 | 36167篇 |
特种医学 | 18642篇 |
外国民族医学 | 63篇 |
外科学 | 77229篇 |
综合类 | 8456篇 |
一般理论 | 122篇 |
预防医学 | 38909篇 |
眼科学 | 12105篇 |
药学 | 40833篇 |
中国医学 | 1037篇 |
肿瘤学 | 28211篇 |
出版年
2018年 | 5024篇 |
2016年 | 4185篇 |
2015年 | 4686篇 |
2014年 | 6251篇 |
2013年 | 9766篇 |
2012年 | 13225篇 |
2011年 | 14595篇 |
2010年 | 8507篇 |
2009年 | 7946篇 |
2008年 | 13927篇 |
2007年 | 14943篇 |
2006年 | 15149篇 |
2005年 | 14560篇 |
2004年 | 14182篇 |
2003年 | 13492篇 |
2002年 | 13323篇 |
2001年 | 24110篇 |
2000年 | 25082篇 |
1999年 | 20504篇 |
1998年 | 5165篇 |
1997年 | 4432篇 |
1996年 | 4771篇 |
1995年 | 4602篇 |
1994年 | 4313篇 |
1992年 | 15726篇 |
1991年 | 16318篇 |
1990年 | 16425篇 |
1989年 | 15795篇 |
1988年 | 14570篇 |
1987年 | 14417篇 |
1986年 | 13596篇 |
1985年 | 12983篇 |
1984年 | 9621篇 |
1983年 | 8238篇 |
1982年 | 4544篇 |
1981年 | 4218篇 |
1979年 | 9408篇 |
1978年 | 6846篇 |
1977年 | 5755篇 |
1976年 | 5590篇 |
1975年 | 6381篇 |
1974年 | 7632篇 |
1973年 | 7127篇 |
1972年 | 6955篇 |
1971年 | 6686篇 |
1970年 | 6170篇 |
1969年 | 5888篇 |
1968年 | 5561篇 |
1967年 | 5011篇 |
1966年 | 4450篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Rozhkov V. P. Trifonov M. I. Soroko S. I. 《Neuroscience and behavioral physiology》2022,52(3):383-394
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia... 相似文献
2.
3.
4.
5.
6.
Robert J. Motzer MD David F. McDermott MD Bernard Escudier MD Mauricio Burotto MD Toni K. Choueiri MD Hans J. Hammers MD PhD Philippe Barthélémy MD PhD Elizabeth R. Plimack MD Camillo Porta MD Saby George MD Thomas Powles MD Frede Donskov MD PhD Howard Gurney MD Christian K. Kollmannsberger MD Marc-Oliver Grimm MD Carlos Barrios MD Yoshihiko Tomita MD PhD Daniel Castellano MD Viktor Grünwald MD PhD Brian I. Rini MD M. Brent McHenry PhD Chung-Wei Lee MD PhD Jennifer McCarthy MA Flavia Ejzykowicz PhD Nizar M. Tannir MD 《Cancer》2022,128(11):2085-2097
7.
8.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
9.
Lykov A. P. Uvarov I. P. Gevorgiz R. G. Zheleznova S. N. 《Bulletin of experimental biology and medicine》2022,172(3):301-304
Bulletin of Experimental Biology and Medicine - We studied the effect of microalgae of various systematic groups added to the ration on the biochemical parameters of blood serum and liver and... 相似文献
10.
Rajiv V. Dave Baek Kim Alona Courtney Rachel OConnell Tim Rattay Vicky P. Taxiarchi Jamie J. Kirkham Elizabeth M. Camacho Patricia Fairbrother Nisha Sharma Christopher W. J. Cartlidge Kieran Horgan Stuart A. McIntosh Daniel R. Leff Raghavan Vidya Shelley Potter Chris Holcombe Ellen Copson Charlotte E. Coles Ramsey I. Cutress Ashu Gandhi Cliona C. Kirwan 《British journal of cancer》2021,124(11):1785
Background The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions.Methods This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting.Findings Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey.Conclusions The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown.Subject terms: Breast cancer, Surgical oncology, Health care economics, Quality of life, Health policy 相似文献